The FDA announced Thursday that it is launching an independent investigation into the presence of heavy metals in tampons. This decision comes in response to a July study published in Environmental International, which revealed that 16 chemicals, including lead, arsenic, and cadmium, were found in tampons from 14 companies.
The investigation was spurred by Sen. Patty Murray (D-WA), who sent a letter to the FDA calling for action. Murray, a long-time advocate for women’s health, emphasized that millions of women use tampons daily, making it crucial to address any safety concerns. “For too long, women’s health has been overlooked,” Murray said. “We must ensure that these products are safe for the millions of women who rely on them.”
Heavy metals like lead and cadmium can cause severe health issues, including kidney disease, cancer, and fertility problems. With tampons being a widely used product, the potential risks are significant. Up to 86% of women use tampons, and the discovery of harmful chemicals has raised widespread concern.
The original study did not investigate whether these metals could be absorbed into the body when tampons are used. The FDA’s review will focus on determining if the chemicals can pass through the vaginal wall, which could pose even greater risks.
As the investigation unfolds, the FDA is working on a comprehensive response to Murray’s concerns. For now, the agency is urging caution as it seeks to understand the full impact of these findings on women’s health.
